Manager Of Quality Control

The petition was approved based on the satisfaction of at least three EB-1A criteria: authorship of scholarly articles, participation as a judge of the work of others, and original scientific contributions of major significance. Specific metrics included 8 peer-reviewed publications in elite journals like Nature Microbiology, 260 citations placing him in the top 1% of his field, and the completion of over 20 peer reviews for high-impact journals.

The petition was approved based on the petitioner's authorship of 27 peer-reviewed articles and 17 abstracts, which garnered 485 citations from researchers in over 40 countries. His work ranked in the top 10% of most-cited publications in pharmacology for several years. Additionally, he completed over 60 peer reviews and received research grants from the NIH and the National Research Foundation of South Korea.

The petition was approved based on meeting at least three EB-1A criteria: scholarly articles, peer review, and original contributions. Specific metrics included 17 peer-reviewed journal articles, 904 citations on Google Scholar, and 24 instances of peer review service. The case also highlighted significant research funding from the National Cancer Institute and National Science Foundation as evidence of the work's importance.

The petition was approved based on a record of 17 peer-reviewed articles and 1,210 citations, demonstrating extensive independent reliance by the research community. The petitioner also provided evidence of 13 completed manuscript reviews for respected journals. Approval was further supported by original contributions in structure-guided HIV vaccine design and nucleic acid-based strategies for SARS-CoV-2.